CG0070

· CG Oncology, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CG0070, covering 2008-10-03 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer [Phase 2]

See pricing